share_log

8-K/A: Current report (Amendment)

8-K/A: Current report (Amendment)

8-K/A：重大事件(修正)
美股SEC公告 ·  10/21 17:05

Moomoo AI 已提取核心信息

Heart Test Laboratories, Inc., now known as HeartSciences Inc., has officially changed its corporate name following the filing of a Certificate of Amendment with the Secretary of State of Texas on October 11, 2024. This name change was previously approved by shareholders during the Annual Meeting on January 17, 2024. The company's common stock and public warrants are expected to commence trading under the new name on The Nasdaq Capital Market from October 23, 2024. Despite the name change, the ticker symbols (HSCS for common stock and HSCSW for warrants) and the CUSIP numbers for the company's securities will remain unchanged. Current stock certificates and public warrants will continue to be valid and do not require exchange. The name change is the sole alteration to the company's Amended and Restated Certificate of Formation, with no other changes reported.
Heart Test Laboratories, Inc., now known as HeartSciences Inc., has officially changed its corporate name following the filing of a Certificate of Amendment with the Secretary of State of Texas on October 11, 2024. This name change was previously approved by shareholders during the Annual Meeting on January 17, 2024. The company's common stock and public warrants are expected to commence trading under the new name on The Nasdaq Capital Market from October 23, 2024. Despite the name change, the ticker symbols (HSCS for common stock and HSCSW for warrants) and the CUSIP numbers for the company's securities will remain unchanged. Current stock certificates and public warrants will continue to be valid and do not require exchange. The name change is the sole alteration to the company's Amended and Restated Certificate of Formation, with no other changes reported.
Heart Test Laboratories, Inc.，现已更名为HeartSciences Inc.，根据2024年10月11日向德克萨斯州国务卿提交的修正证书正式更改了其公司名称。此名称更改此前已于2024年1月17日的年度股东大会上获得了股东批准。预计该公司的普通股和公开逐笔明细将于2024年10月23日起在纳斯达克资本市场以新名称开始交易。尽管更名，公司的股票代号（普通股为HSCS，逐笔明细为HSCSW）及公司证券的CUSIP编号将保持不变。现有的股票证书和公开逐笔明细仍然有效，不需要进行交换。更名是公司修正和重订成立证书的唯一变更，未报告任何其他变更。
Heart Test Laboratories, Inc.，现已更名为HeartSciences Inc.，根据2024年10月11日向德克萨斯州国务卿提交的修正证书正式更改了其公司名称。此名称更改此前已于2024年1月17日的年度股东大会上获得了股东批准。预计该公司的普通股和公开逐笔明细将于2024年10月23日起在纳斯达克资本市场以新名称开始交易。尽管更名，公司的股票代号（普通股为HSCS，逐笔明细为HSCSW）及公司证券的CUSIP编号将保持不变。现有的股票证书和公开逐笔明细仍然有效，不需要进行交换。更名是公司修正和重订成立证书的唯一变更，未报告任何其他变更。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间